BCL2 and cancer: Proteins of the B-cell lymphoma 2 (Bcl-2) family play a role in the regulation of apoptosis and confer resistance to traditional cytotoxic chemotherapy and monoclonal antibodies, making Bcl-2 an attractive target for therapeutic intervention in cancers.